Multimodal self-supervised deep learning for precision cancer medicine
Description of the granted funding
Precision cancer medicine aims to obtain treatment-impacting information on individual cancer cases by performing in-depth cancer profiling. Profiling often includes tissue imaging and, more recently, sequencing of cancer genomes. Machine learning methods such as ChatGPT have been shown to be capable of solving a wide range of problems expressed in natural language or as images. Here, we seek to employ similar machine learning approaches in precision cancer medicine to answer questions such as what is the molecular subtype and suitable treatments for particular cancer, or whether a cancer may be aggressive or indolent. To do this, we will develop machine learning models that do not require guidance by experts, but instead learn to automatically recognize similarities and differences between cancers based on histological images and genomics data. These models can then be used to create software tools to assist clinicians to better diagnose and treat patients.
Show moreStarting year
2025
End year
2029
Granted funding
Funder
Research Council of Finland
Funding instrument
Academy projects
Decision maker
Scientific Council for Natural Sciences and Engineering
12.06.2025
12.06.2025
Other information
Funding decision number
372081
Fields of science
Biomedicine
Research fields
Systeemibiologia, bioinformatiikka
Identified topics
cancer